For lung cancers, EGFR mutations have been linked with decreased cytotoxic T cell infiltration9,10, whereas for colorectal cancers, KRAS mutations have been associated with increased marrow-derived suppressor cell infiltration and the subsequent decreased infiltration of cytotoxic T cells11,12. This evidence concerns the gene KRAS and lung cancer.